Patents by Inventor Minoru Sasaki

Minoru Sasaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210118710
    Abstract: The present disclosure provides a wafer inspection technology that involves less degradation of the image quality even when an object to be observed has a variation in height due to warpage, etc. of a wafer. This wafer inspection apparatus obtains an image with less degradation by: adjusting the focal point of an observation optical system to a height measured by a height sensor for measuring wafer surface heights; and further, correcting a switching signal for a CCD line sensor on the basis of stage position data and optical magnification data corresponding to the height so as to make a correction corresponding to the wafer surface height.
    Type: Application
    Filed: May 30, 2018
    Publication date: April 22, 2021
    Inventors: Akira DOI, Minoru SASAKI, Masaki HASEGAWA, Hironori OGAWA, Tomohiko OGATA, Yuko OKADA
  • Publication number: 20210087186
    Abstract: The present invention provides a compound having a glucosylceramide lowering action (e.g., promoting glucosylceramide metabolism, inhibition of glucosylceramide synthesis, promoting glucosylceramide catabolism, etc.), which is expected to be useful as an agent for the prophylaxis or treatment of lysosome diseases (e.g., Gaucher's disease), neurodegenerative diseases (e.g., Parkinson's disease, Lewy body dementia, multiple-system atrophy) and the like. The present invention relates to a compound represented by the formula (I) wherein each symbol is as described in the specification, or a salt thereof.
    Type: Application
    Filed: January 30, 2019
    Publication date: March 25, 2021
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Yuta TANAKA, Tomohiro OHASHI, Zenichi IKEDA, Yuta TANAKA, Florian P√úNNER, Takeshi YAMAMOTO, Keiko KAKEGAWA, Fumiaki KIKUCHI, Nao MORISHITA, Takahito KASAHARA, Masaki SETO, Minoru NAKAMURA, Kazuaki TAKAMI, Masataka MURAKAMI, Masaki DAINI, Satoshi MIKAMI, Minoru SASAKI
  • Publication number: 20200283620
    Abstract: Resin compositions including (A) an epoxy resin, (B) a curing agent, and (C) an inorganic filler, in which a chloride ion content included in the resin composition measured in accordance with a sample combustion ion chromatography method (BS EN 14582 2007) is 50 ppm or less are capable of forming a cured product having excellent adhesion with a conductive layer even after the HAST test.
    Type: Application
    Filed: March 5, 2020
    Publication date: September 10, 2020
    Applicant: AJINOMOTO CO., INC.
    Inventors: Hiroyuki SAKAUCHI, Minoru SASAKI, Mariko MIYOSHI
  • Patent number: 10435399
    Abstract: The present invention provides a heterocyclic compound having a HDAC inhibitory action, and useful for the treatment of central nervous system diseases including neurodegenerative disease, and the like, and a medicament comprising the compound. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: October 8, 2019
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Masahiro Ito, Hideyuki Sugiyama, Osamu Kubo, Fumiaki Kikuchi, Takeshi Yasui, Keiko Kakegawa, Zenichi Ikeda, Tohru Miyazaki, Yasuyoshi Arikawa, Tomohiro Okawa, Jinichi Yonemori, Akinori Toita, Takuto Kojima, Yasutomi Asano, Ayumu Sato, Hironobu Maezaki, Shinobu Sasaki, Hironori Kokubo, Misaki Homma, Minoru Sasaki, Yasuhiro Imaeda
  • Patent number: 10422820
    Abstract: A voltage sensor includes a vibrator configured to be supported by a mechanical supporting portion and to be given a floating potential, a drive electrode configured to be disposed adjacent to the vibrator and to resonate the vibrator with applied AC voltage, a driver configured to apply an AC voltage that crosses 0 V to the drive electrode, a fixed electrode configured to be disposed adjacent to the vibrator with a gap formed between the fixed electrode and the vibrator, and a calculator configured to detect a magnitude of a measurement target voltage based on a change of a resonant frequency of the vibrator when the measurement target voltage is applied to the fixed electrode.
    Type: Grant
    Filed: October 3, 2017
    Date of Patent: September 24, 2019
    Assignees: YAZAKI CORPORATION, TOYOTA SCHOOL FOUNDATION
    Inventors: Hiroki Ishihara, Makoto Ishii, Minoru Sasaki
  • Patent number: 10401394
    Abstract: A voltage sensor includes an oscillator that has a circular or roughly circular shape and is supported by a mechanical support member, a fixed electrode that has a predetermined gap between the oscillator and the fixed electrode, and a drive electrode that is placed at a position different from the fixed electrode across the oscillator, and to which an AC drive voltage is applied to make the oscillator oscillate. In the voltage sensor, an electrostatic attractive force acts on the oscillator by applying a voltage to the fixed electrode, and a resonance frequency of the oscillator changes.
    Type: Grant
    Filed: May 1, 2017
    Date of Patent: September 3, 2019
    Assignees: YAZAKI CORPORATION, TOYOTA SCHOOL FOUNDATION
    Inventors: Hiroki Ishihara, Makoto Ishii, Minoru Sasaki
  • Publication number: 20190135799
    Abstract: The present invention provides a heterocyclic compound having a HDAC inhibitory action, and useful for the treatment of central nervous system diseases including neurodegenerative disease, and the like, and a medicament comprising the compound. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.
    Type: Application
    Filed: July 30, 2018
    Publication date: May 9, 2019
    Inventors: Masahiro ITO, Hideyuki SUGIYAMA, Osamu KUBO, Fumiaki KIKUCHI, Takeshi YASUI, Keiko KAKEGAWA, Zenichi IKEDA, Tohru MIYAZAKI, Yasuyoshi ARIKAWA, Tomohiro OKAWA, Jinichi YONEMORI, Akinori TOITA, Takuto KOJIMA, Yasutomi ASANO, Ayumu SATO, Hironobu MAEZAKI, Shinobu SASAKI, Hironori KOKUBO, Misaki HOMMA, Minoru SASAKI, Yasuhiro IMAEDA
  • Publication number: 20180210340
    Abstract: Provided is a film for application to a 3D sample, the film including a photoresist layer that has alignment or direction marks thereon. After the fine pattern of the photoresist layer or coat is exposed, the photoresist layer is applied to a desired position of the 3D sample by aligning the alignment or direction marks of the film with alignment or direction marks on the 3D sample. This allows for transfer of an appropriate fine pattern. Part or all of the thickness or area of the photoresist layer is developed to form projections or depressions in the photoresist layer before the film is applied to the 3D sample.
    Type: Application
    Filed: January 23, 2018
    Publication date: July 26, 2018
    Inventor: Minoru SASAKI
  • Patent number: 10023544
    Abstract: A fused heterocyclic compound having an enteropeptidase inhibitory action and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided. Specifically, a compound represented by the following formula (I): wherein each symbol is as defined herein, or a salt thereof and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided.
    Type: Grant
    Filed: February 12, 2015
    Date of Patent: July 17, 2018
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Zenichi Ikeda, Minoru Sasaki, Keiko Kakegawa, Fumiaki Kikuchi, Yoichi Nishikawa
  • Patent number: 10017487
    Abstract: The present invention relates to a condensed heterocyclic compound that has an enteropeptidase inhibitory effect, and use of the compound as a medicament for the treatment or prevention of obesity, diabetes mellitus, or the like. Specifically, the present invention relates to a compound represented by the formula (I) or a salt thereof, and use of the compound as a medicament for the treatment or prevention of obesity, diabetes mellitus, or the like [in the formula, each symbol is as defined in the specification].
    Type: Grant
    Filed: March 25, 2016
    Date of Patent: July 10, 2018
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Keiko Kakegawa, Zenichi Ikeda, Minoru Sasaki, Fumiaki Kikuchi, Yoichi Nishikawa
  • Patent number: 9975903
    Abstract: The present invention relates to a condensed heterocyclic compound that has an enteropeptidase inhibitory effect and is useful in the treatment or prevention of obesity, diabetes mellitus, or the like, and a medicament containing the same. Specifically, the present invention relates to a compound represented by the following formula (I) or a salt thereof, and a medicament containing the same [in the formula, each symbol is as defined in the specification].
    Type: Grant
    Filed: December 24, 2015
    Date of Patent: May 22, 2018
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Minoru Sasaki, Fumiaki Kikuchi, Zenichi Ikeda, Keiko Kakegawa, Yoichi Nishikawa, Shigekazu Sasaki, Koichiro Fukuda, Kazuaki Takami, Yoshihiro Banno, Masahiro Kamaura
  • Patent number: 9969705
    Abstract: A fused heterocyclic compound having an enteropeptidase inhibitory action and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided. Specifically, a compound represented by the following formula (I): wherein each symbol is as defined herein, or a salt thereof and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided.
    Type: Grant
    Filed: February 12, 2015
    Date of Patent: May 15, 2018
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Minoru Sasaki, Keiko Kakegawa, Fumiaki Kikuchi, Zenichi Ikeda, Yoichi Nishikawa
  • Publication number: 20180100880
    Abstract: A voltage sensor includes a vibrator configured to be supported by a mechanical supporting portion and to be given a floating potential, a drive electrode configured to be disposed adjacent to the vibrator and to resonate the vibrator with applied AC voltage, a driver configured to apply an AC voltage that crosses 0 V to the drive electrode, a fixed electrode configured to be disposed adjacent to the vibrator with a gap formed between the fixed electrode and the vibrator, and a calculator configured to detect a magnitude of a measurement target voltage based on a change of a resonant frequency of the vibrator when the measurement target voltage is applied to the fixed electrode.
    Type: Application
    Filed: October 3, 2017
    Publication date: April 12, 2018
    Inventors: Hiroki Ishihara, Makoto Ishii, Minoru Sasaki
  • Publication number: 20180072694
    Abstract: The present invention relates to a condensed heterocyclic compound that has an enteropeptidase inhibitory effect, and use of the compound as a medicament for the treatment or prevention of obesity, diabetes mellitus, or the like. Specifically, the present invention relates to a compound represented by the formula (I) or a salt thereof, and use of the compound as a medicament for the treatment or prevention of obesity, diabetes mellitus, or the like [in the formula, each symbol is as defined in the specification].
    Type: Application
    Filed: March 25, 2016
    Publication date: March 15, 2018
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Keiko Kakegawa, Zenichi IKEDA, Minoru SASAKI, Fumiaki KIKUCHI, Yoichi NISHIKAWA
  • Publication number: 20170349605
    Abstract: The present invention relates to a condensed heterocyclic compound that has an enteropeptidase inhibitory effect and is useful in the treatment or prevention of obesity, diabetes mellitus, or the like, and a medicament containing the same. Specifically, the present invention relates to a compound represented by the following formula (I) or a salt thereof, and a medicament containing the same [in the formula, each symbol is as defined in the specification].
    Type: Application
    Filed: December 24, 2015
    Publication date: December 7, 2017
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Minoru SASAKI, Fumiaki KIKUCHI, Zenichi IKEDA, Keiko KAKEGAWA, Yoichi NISHIKAWA, Shigekazu SASAKI, Koichiro FUKUDA, Kazuaki TAKAMI, Yoshihiro BANNO, Masahiro KAMAURA
  • Publication number: 20170322238
    Abstract: A voltage sensor includes an oscillator that has a circular or roughly circular shape and is supported by a mechanical support member, a fixed electrode that has a predetermined gap between the oscillator and the fixed electrode, and a drive electrode that is placed at a position different from the fixed electrode across the oscillator, and to which an AC drive voltage is applied to make the oscillator oscillate. In the voltage sensor, an electrostatic attractive force acts on the oscillator by applying a voltage to the fixed electrode, and a resonance frequency of the oscillator changes.
    Type: Application
    Filed: May 1, 2017
    Publication date: November 9, 2017
    Inventors: Hiroki Ishihara, Makoto Ishii, Minoru Sasaki
  • Patent number: 9803904
    Abstract: A refrigerant cycle device for a vehicle includes a compressor which compresses and discharges refrigerant, a discharge capacity control portion which controls a discharge capacity of the compressor. The refrigerant cycle device further includes a noise determination portion which determines whether an audible noise other than a refrigerant passing noise is in a low noise state, and/or a load determination portion which determines whether an air-conditioning thermal load is in a high load state. The discharge capacity control portion performs a gradual activation control in which the discharge capacity of the compressor is set to be lower than that determined in a normal control, when the noise determination portion determines that the audible noise is in the low noise state, and/or when the load determination portion determines that the air-conditioning thermal load is in the high load state, at an activation time of the compressor.
    Type: Grant
    Filed: May 16, 2012
    Date of Patent: October 31, 2017
    Assignee: DENSO CORPORATION
    Inventors: Minoru Sasaki, Takashi Yamanaka, Takeshi Wakisaka, Motohiro Yamaguchi, Yasuaki Sasaki, Ken Matsunaga
  • Publication number: 20160355494
    Abstract: A fused heterocyclic compound having an enteropeptidase inhibitory action and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided. Specifically, a compound represented by the following formula (I): wherein each symbol is as defined herein, or a salt thereof and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided.
    Type: Application
    Filed: February 12, 2015
    Publication date: December 8, 2016
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Minoru SASAKI, Keiko KAKEGAWA, Fumiaki KIKUCHI, Zenichi IKEDA, Yoichi NISHIKAWA
  • Publication number: 20160347724
    Abstract: A fused heterocyclic compound having an enteropeptidase inhibitory action and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided. Specifically, a compound represented by the following formula (I): wherein each symbol is as defined herein, or a salt thereof and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided.
    Type: Application
    Filed: February 12, 2015
    Publication date: December 1, 2016
    Applicant: Takeda Pharmaceutical Company Limited
    Inventors: Zenichi IKEDA, Minoru SASAKI, Keiko KAKEGAWA, Fumiaki KIKUCHI, Yoichi NISHIKAWA
  • Patent number: 9428470
    Abstract: A fused heterocyclic compound having an enteropeptidase inhibitory action and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided. Specifically, a compound represented by the following formula (I): wherein each symbol is as defined herein, or a salt thereof and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided.
    Type: Grant
    Filed: February 11, 2015
    Date of Patent: August 30, 2016
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Zenichi Ikeda, Minoru Sasaki, Keiko Kakegawa, Fumiaki Kikuchi, Yoichi Nishikawa